Improving cancer biomarker discovery and design
Our simple models accurately predicted and explained treatment responses for Checkmate Pharmaceuticals
Reducing R&D risk for top-10 pharmaceutical company
Our explainable models yielded a 44 percentage point improvement in catching toxic drugs in the drug development pipeline